Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seletracetam in Refractory Partial Onset Seizures
NCT00152451Phase 2Completed
- Sponsor
- UCB
- Start
- May 2005
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of seletracetam in focal onset seizure, sponsored by UCB. Primary endpoint: Percentage Change From Baseline in Seizure Frequency Per Week of Partial Onset Seizures (Type I) During the Up-titration Period. Started May 2005; status: completed.
02
Drugs
seletracetam
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00152451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152451.